Page last updated: 2024-09-02

kt 5823 and taurochenodeoxycholic acid

kt 5823 has been researched along with taurochenodeoxycholic acid in 1 studies

Compound Research Comparison

Studies
(kt 5823)
Trials
(kt 5823)
Recent Studies (post-2010)
(kt 5823)
Studies
(taurochenodeoxycholic acid)
Trials
(taurochenodeoxycholic acid)
Recent Studies (post-2010) (taurochenodeoxycholic acid)
31705987327423

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, F; Ji, L; Liang, X; Shi, Z; Su, F; Tie, R; Xing, W; Yu, J; Yu, L; Zhang, H; Zhu, M1

Other Studies

1 other study(ies) available for kt 5823 and taurochenodeoxycholic acid

ArticleYear
Vasonatrin peptide attenuates myocardial ischemia-reperfusion injury in diabetic rats and underlying mechanisms.
    American journal of physiology. Heart and circulatory physiology, 2015, Feb-15, Volume: 308, Issue:4

    Topics: Animals; Apoptosis; Atrial Natriuretic Factor; Carbazoles; Caspase 3; Cell Hypoxia; Cell Line; Creatine Kinase; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Diabetes Mellitus, Experimental; Endoplasmic Reticulum Stress; Heart Ventricles; Male; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Taurochenodeoxycholic Acid; Transcription Factor CHOP; Ventricular Function

2015